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Receptor specificity restricts influenza virus cross species 
transmission, with SAα2,6 Gal and SAα2,3 Gal sialic acids 
recognized by human and avian influenza viruses, respectively. 
This study investigated the distribution of these two species 
of sialic acids in the human respiratory tract. The SAα2,3 Gal 
species was infrequently detected in the upper respiratory 
tract, but prevalent in the lower part, while the SAα2,6 Gal 
species is more common in the upper respiratory tract.  Though 
alveolus cells are more susceptible than trachea and bronchus 
epithelial cells to avian influenza H5N1 virus infection in the 
ex vivo experiment, H5N1 virus was found to infect the upper 
respiratory tract epithelial cells of a human case. It was also 
found that H5N1 virus infection occurs in the epithelial cells 
of the respiratory tract which do not express detectable SA 
α2,3Gal. These observations may be important to investigate 
further if the currently-observed limited human to human 
transmission by H5N1 virus is associated with the differential 
expression of SAα2,3 Gal in human upper respiratory tract 
among individuals. 
Introduction
The binding of influenza virus to host cells is mediated via the 
viral surface protein haemagglutinin, which recognizes cell 
surface glycoproteins containing terminal sialic acid residues. 
Haemagglutinin proteins from human and avian influenza 
viruses differ in their ability to recognize different receptor 
structures of sialyloligosaccharide molecules on host cell 
membrane [1, 2]. Host tropism of influenza viruses is restricted 
by receptor specificity. Human influenza viruses preferentially 
bind to the terminal sialic acid with an α2,6 linkage to the 
underlying galactose (SAα2,6Gal), whereas avian and equine 
viruses prefer an α2,3 linkage to the underlying galactose 
(SAα2,3Gal )[2,3], which predominate in their respective target 
species. In recent years, however, avian influenza virus H5N1 
subtype, has repeatedly crossed host barrier and infected 
humans. Over 300 humans cases have been confirmed in 
various affected countries by the World Health Organization 
since 2003 when H5N1 virus human infection reemerged 
in Hong Kong [5]. Genetic analysis has demonstrated that 
the H5N1 viruses causing human infections up to now are 
still of the avian type [6, 7, 8]. The molecular mechanism 
underlying such cross species transmission is not clear though 
it is generally believed that the availability (or presence) of 
α2,3 linkage terminal sialic acid receptor in human airway 
may attribute to the susceptibility to avian influenza virus 
infection. H5N1 virus only showed inefficient human to human 
transmission up to this stage [9].  It is also suspected that some 
individuals with high exposure to H5N1 virus do not become 
infected due to an inherent reduced susceptibility to this virus. 
Two recent studies demonstrated SAα2,3Gal expression and 
influenza virus binding in the bronchioles and alveoli of the 
human respiratory tract, indicating that avian influenza viruses 
can replicate relatively efficiently in the lower respiratory 
tract, providing a possible explanation for inefficient human-
to-human transmission of avian influenza viruses [10, 11]. 
In another study, H5N1 virus was found to be able to infect 
epithelial cells of the human upper respiratory tract in an ex 
vivo infection model [12]. However, the prevalence and the 
extent of expression of SAα2,3Gal and SAα2,6Gal in the human 
respiratory tract have still not been fully investigated. In this 
report we studied the distribution and prevalence of SAα2,3Gal 
and SAα2,6Gal on the airway epithelia of different anatomical 
areas of the human respiratory tract. Our results demonstrated 
that SAα2,6Gal predominates in the upper respiratory tract, 
while SAα2,3Gal is patchily expressed in the upper respiratory 
tract of a portion of individuals but more prevalent in the 
lower part of the respiratory tract. Examination of ex vivo and 
in vivo H5N1 virus-infected human tissues indicated H5N1 
virus infection of upper respiratory tract may not completely 
dependent upon avian influenza virus receptor. 
Materials and Methods
Tissue samples. 144 paraffin-embedded human respiratory 
tissue sections from 88 patients were obtained from the 
pathological archives in several local hospitals in Guangxi and 
Guangdong provinces, China. The age of the patients ranged 
from antenatal to 76 years old. Different anatomical parts 
of respiratory tract were included based on the availability 
of tissues, and were then histologically classified as trachea, 
bronchus, bronchiole and alveolus. Paraffin-embedded 
respiratory tissue sections from a H5N1 human infection case 
[4] in Hong Kong in 2003 were also included in this study. 
Lectin histochemical staining of human airway tissues. Expression 
of SA α2,6Gal and SAα2,3Gal was examined using biotinylated 
lectins: Sambucus nigra lectin (SNA, EY Laboratories, Inc., 
California, USA), and Macckia amaurensis lectin (MAA-I & 
MAA-II, Vector Laboratories, California, USA). Deparaffinized 
and rehydrated tissue sections were blocked consecutively 
for 15 minutes with avidin D and biotin solutions (Vector 
Laboratories) to reduce nonspecific binding of endogenous 
biotin and avidin. These sections were then incubated with 
biotin-labeled MAA-II or SNA at a concentration of 10µg/ml or 
1µg/ml, respectively, for 60 minutes at room temperature, and 
then with streptavidin/peroxidase complex reagent (Vector 
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Laboratories) for 30 minutes followed by color development 
using 3,3’-diaminobenzidine (DAB, Vector Laboratories). 
Ex Vivo infection of human respiratory tissue.  For the ex vivo 
infection study, one H5N1 isolate from human infection, 
A/HK/212/03 [4] and two avian H5N1 influenza viruses, DK/
GX4444/05 and DK/GX3546/05 [7,8], were passaged once in 
10-day embryonated chicken eggs and stored at –80°C until 
use. Eight cases of surgically-removed human respiratory 
tract tissues from lung cancer or non-cancer patients were 
obtained from local hospitals in Guangdong province in 
accordance to the local Institutional Ethical Review Board’s 
approved protocols. The tissues were cut into small pieces of 
about 0.2cm3 and infected with 103 TCID
50
 of each H5N1 virus 
in a 500µl inoculum. The virus was removed after a one hour 
absorption at 37°C/5% CO
2
, and tissues were further incubated 
at 37°C/5% CO
2
 for 24 hour in 3ml of serum-free F12K Nutrient 
Mixture (GIBCO, New York, USA) supplemented with 25mM 
HEPES buffer solution  and 1% Antibiotic-Antimycotic 
(GIBCO). The infected tissues were then fixed in 10% neutral 
formalin for 24 hours before being histologically sectioned for 
immunohistochemical detection of influenza nucleoprotein 
(NP). 
Immunohistochemical staining of tissues. For detection of 
influenza A nucleoprotein (NP) in human tissues, sections 
were blocked with 1% bovine serum albumin/PBS, stained 
with a anti-influenza nucleoprotein monoclonal antibody 
(17H4 clone) raised with  H5N1 strain CK/Yu22/02 [8] at 1:5000 
dilution at 4°C for overnight and then incubated with goat anti-
mouse IgG, H & L chain specific biotin conjugate (Calbiochem) 
at 1:2000 dilution for 30 minutes at room temperature. Tissue 
blocks were then incubated with streptavidin/ peroxidase 
complex reagent (Vector Laboratories) for 30 minutes at room 
temperature. Color development and images capture were 
carried out as described above. 
Results and Discussion
Distribution of influenza virus receptors in human respiratory 
tract. 144 respiratory tissue sections including 10 tracheas, 40 
bronchi, 46 bronchioles and 48 alveolar tissues were studied 
by lectin histochemistry methods. SAα2,6Gal and SAα2,3Gal 
recognized by SNA or MAA-II respectively on the apical 
epithelial surface were counted as positive in this study, while 
relative intensity of staining achieved with the lectins was not 
used as a direct quantitation measure of sialic acid distribution, 
because the relative affinities of the lectins, and the degree 
of biotinylation may differ among different preparations. 
SAα2,3Gal was only detected in a small portion of the upper 
respiratory tract tissues, with 20% in trachea and 42.5% in 
bronchus sections showing positive staining. As shown in 
Figure 1A and B, only sporadic SAα2,3Gal positive cells were 
observed in each positive sample. In contrast, SAα2,3Gal 
was more regularly observed in the lower respiratory tract 
epithelial cells, with 68.7% of the bronchiolar and 79% of 
alveolar tissues showing positive staining in all cases examined 
(data not shown).  In contrast, expression of human influenza 
virus receptor, SAα2,6Gal, was mainly detected in the 
upper respiratory tract and to a lesser degree in the alveolar 
epithelium, with 100% in trachea, 97.5% in bronchus, 80.4% in 
bronchioles but only 43.8% in alveolar tissues (data not shown). 
These results, consistent with previous studies, suggested that 
lower respiratory tract may be more susceptible to avian H5N1 
influenza virus infection for its relatively higher expression of 
SAα2,3Gal. However, the observation of SAα2,3Gal expression 
in some epithelial cells of tissues from the upper respiratory 
tract argues one possibility that the currently-observed 
limited human to human transmission by H5N1 virus may be 
associated with the differential expression of SAα2,3 Gal in 
human upper respiratory tract among individuals.                          
 
Figure 1. Detection of SA α2,3 Gal expression in human respiratory tract 
tissues, trachea (A) and bronchus (B), by immunostaining with lectin probes 
MAA-II; Detection of influenza viral antigen (nucleoprotein) in trachea (C) 
from one H5N1 virus infected patient and in ex vivo infected bronchus 
tissue (D) with avian H5N1 virus, DK/GX3546/05, with immunohistochemical 
staining.  Viral nucleoprotein positive cells  were shown in brown color.
 
Avian H5N1 virus infection in human respiratory tract tissues. 
Previous reports suggested that alveolus cells in the lung 
represent the major site for avian H5N1 virus replication 
in human infection [13]. Infection of avian H5N1 influenza 
virus in human upper respiratory tract is less defined. We 
examined tissues of upper respiratory tract obtained from 
a postmortem H5N1 human case in Hong Kong in 2003 [4]. 
Immunohistochemistry staining of influenza NP protein with a 
monoclonal antibody raised against H5N1 strain Ck/Yu22/2002 
(clone 17H4) showed that influenza viral antigen was present 
in tracheal  (Figure 1C), bronchial and also in alveolar epithelial 
cells data not shown).  To further explore the possibility of 
H5N1 virus infection in the upper respiratory tract, we then 
performed H5N1 virus infection in ex vivo cultured human 
respiratory tissues removed from the respiratory tract of 
patients suffering non-infectious diseases. The H5N1 human 
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strain (A/HK212/03) we tested was isolated from a fatal human 
infection case [4]. A previous receptor binding study found 
that this strain can bind to both avian and human receptors 
[14]. These ex vivo infection tests further demonstrated that 
this virus infected both bronchial and alveolar epithelial cells 
with similar efficiency. In this study, we also tested two avian 
H5N1 isolates, DK/GX4444/05 and DK/GX3546/05 (data not 
shown). Genetic analysis of the haemagglutinin gene of these 
two viruses indicated they are typical avian type [7, 8]. We 
could also demonstrate that bronchial and alveolar epithelial 
cells were both infected by these viruses (figure 1D). This 
evidence supports the notion that upper respiratory tract 
is also susceptible to avian H5N1 virus infection. It remains 
to be determined if the presence of SAα2,3Gal in the upper 
respiratory tract would predispose towards susceptibility to 
H5N1 virus infection. It is noteworthy that, when sequential 
tissue sections from ex vivo H5N1 infected bronchus tissues 
were stained for both virus replication and the expression of 
influenza receptors, in the area where H5N1 virus infection 
was observed, staining with the lectin MAA-II failed to detect 
SAα2,3Gal species (Figure 2 A, B and C). However, a strong 
positive staining of SNA and a patchy signal of MAA-I lectin 
staining were observed in the same region. Previous reports on 
lectin affinity studies had showed that MAA-I also reacts with 
other species of sialic acids [15], and the inner fragment of the 
carbohydrate chain in sialic acid-containing oligosaccharides 
may also be involved in influenza virus entry into the target 
cells [16, 17]. However, the exact mechanism of how H5N1 
avian influenza virus infection epithelial cells which do not 
express SAα2,3Gal remains to be investigated.  
Figure 2. H5N1 virus infects bronchus cells without expressing  SAα2,3Gal. 
Human bronchus tissue infected with DK/GX/4444/05 was stained for viral 
antigen (NP) expression, consecutive sections of bronchus tissue were stained 
with monoclonal antibody specific for viral antigen (NP) (A), with lectin 
MAA_II specific for avian influenza virus receptor SAα2,3Galβ1-3GalNAc (B), 
and with MAA for both SAα2,3Galβ1-3GalNAc and SAα2,3Galβ1-4GalNAc 
expression (C), respectively as described in the Materials and Methods. 
It is believed that alteration of receptor specificity is essential 
for the emergence of pandemic viruses from their avian 
progenitors. Whether this change is now happening to H5N1 is 
under intensive investigation. This virus may well be becoming 
less restricted to SAα2,3Gal sialic acid receptor specificity. If 
this virus is adapting to become more like a human influenza 
virus by increasing binding affinity for the SAα2,6Gal sialic acid 
receptors which are more widely expressed throughout the 
human respiratory tract, an imminent pandemic seems likely. 
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